Skip to product information
1 of 1

TCI

CAS 90776-59-3

4-Nitrobenzyl (4R,5S,6S)-3-[(Diphenylphosphono)oxy]-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[320]hept-2-ene-2-carboxylate TCI N1231

4-Nitrobenzyl (4R,5S,6S)-3-[(Diphenylphosphono)oxy]-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[320]hept-2-ene-2-carboxylate TCI N1231

Chemical Identity

CAS No.
90776-59-3
Purity
>98.0%(HPLC)(T)
Regular price Rp 2.545.200,00
Regular price Sale price Rp 2.545.200,00
Sale Sold out
Shipping calculated at checkout.
Berat
Quantity
Pembayaran hanya melalui request quotation dan dilakukan setelah tim kami menghubungi Anda. Mohon cantumkan nomor WhatsApp aktif untuk konfirmasi pesanan & pembuatan invoice. Estimasi pengiriman 2-4 minggu setelah pembayaran.

Dokumen Keamanan & Mutu

CoA (Certificate of Analysis)

Spesifik per batch produksi — diterbitkan dan dikirim bersama barang sesuai nomor lot yang Anda terima.

Contoh CoA segera tersedia.

💬 Minta CoA via WhatsApp

View full details

This complex compound is a key reagent used in pharmaceutical research and drug development. As a building block for the synthesis of pharmacological compounds, it plays a vital role in the creation of active ingredients with therapeutic effects. Its molecular structure enables specific chemical reactions, making it essential for advanced research in medicinal chemistry and pharmacology. This material is widely utilized in laboratories to produce compounds with potential therapeutic applications, supporting the development of new drugs and treatments.

The compound's stability and reactivity make it a preferred choice for high-precision synthetic processes. Its cyclic structure and functional groups allow for targeted chemical modifications, ensuring accurate and reproducible results. This reagent is particularly valued for its ability to participate in complex reactions that require a high degree of control and specificity. Its chemical stability ensures consistent performance across multiple experiments, enhancing the reliability of research outcomes.

In Indonesian laboratories, this compound is commonly used by research institutions and universities focused on pharmaceutical and medicinal chemistry. It supports studies aimed at discovering new therapeutic agents and understanding the mechanisms of drug action. Its application is especially relevant in research settings where precise molecular structures are required for drug development and pharmacological studies.

  • Pharmaceutical Development: This compound is ideal for synthesizing complex pharmaceutical ingredients due to its structural versatility and reactivity.
  • Drug Discovery Research: It supports the creation of novel drug candidates by enabling precise molecular modifications and functional group manipulations.
  • Medicinal Chemistry Studies: Its cyclic structure and functional groups make it suitable for investigating the properties of bioactive molecules.
  • Research in Bioactive Compounds: It is used to develop compounds with potential therapeutic applications, particularly in the field of pharmacology.
  • Advanced Organic Synthesis: Its stability and reactivity make it a valuable reagent for high-precision synthetic pathways in experimental research.

Brand TCI
CAS number 90776-59-3
Molecular formula —
Purity —
Category Chemistry > Pharmaceutical Development and Drug Discovery Research Reagents > Building Blocks for Pharmaceutical Ingredients (for Research and Experimental Use)
Pack sizes —
Physical form —
Storage —

This compound should be stored in a cool, dry place away from direct sunlight and sources of heat. It is recommended to use airtight containers to prevent moisture absorption and contamination. Due to its chemical reactivity, it should be handled in a well-ventilated area, preferably under a fume hood, to ensure safety. Proper personal protective equipment, such as gloves and safety goggles, should be worn when handling this material. It is important to avoid contact with incompatible substances and to follow standard laboratory safety protocols to minimize risks.

—